The objective of this training program is to provide interactive research environments, innovated and competitive research themes and projects, and training opportunities for trainees to become independent investigators in the areas of lung and pulmonary medicine-related biomedical research and medicine.  Qualified applicants, especially from underrepresented minority groups, with a strong interest and commitment to lung and pulmonary research and career development, are encouraged to apply.

The Training program provides an NIH-based stipend for each pre-doctoral and post-doctoral trainee, which covers a large portion of remission fees for each pre-doctoral trainee in graduate study and the health benefit for each post-doctoral trainee in the program.  Trainees are required to participate in mentored research projects, journal clubs, CCRBM seminar series, and other academic activities.  If selected, the trainee will be appointed for one year with the possibility for an additional one and two years support, respectively, for each post- and pre-doctoral trainee, upon successful progression and participation in the program each year.


Application Guidelines

Conditions of Award
As a trainee in this program, it will be your opportunity and responsibility to insure that this support will go towards realizing these goals, in the form of joint publications with cross-disciplinary laboratories, with the grant number cited. 
Our training program is a full-time (one year) curriculum starting on July  1 through June 30 which include a ten-week Summer School, Directed Reading of the Literature in Fall, Winter and Spring quarter, Meet the Faculty, Translational Learning Group Meetings, Distinguished Speakers Seminar Series. We expect full participation of our trainees in all program activities. Throughout the training program, mentoring and career planning is emphasized so the Program can be individualized to best achieve each trainee’s personal goals.  In addition, trainees must actively participate in research/training conferences, including  weekly CCRBM seminar series, specialized seminar series, annual “Lung Day” symposium, work-in-progress, and individual lab meeting sessions to assess trainee progress.


  • Graduate students must be currently enrolled or recently admitted to a Ph.D. graduate program at UC Davis with strong evidence of interest in pursuing an academic career in pulmonary research and/or medicine.  Must commit to a minimum of 9.0 calendar months appointment.
  • Current or prospective postdoctoral and clinical fellows with M.D., Ph.D. DVM or equivalent degree, with a background and strong interest in lung-related biomedical research and/or medicine.  Must commit to a minimum of 12 calendar months appointment.
  • All nominees must be citizens or permanent visa residents of the United States
  • If funded, the students and fellows must present his/her research and participate in the training program activities. All publications must cite the training grant (T32 HL007013).
  • It is essential that the nominees be students and postdoctoral fellows who have the best potential of becoming first-rate independent lung-related biomedical researchers. Scholastic achievement, innovation and interdisciplinary research weigh heavily in the selection.  Collaborations between laboratories and crossing traditional boundaries are also important in the selection process. Research proposal and progress are highly valued as well as excellent GRE scores and graduate level GPA.
  • Candidates will be selected with special efforts given to minority recruitment strategies.
  • Trainees will be selected from the pool of candidates applying to: programs in the CCRBM and Pulmonary Division; graduate groups at UCD; or to individual training faculty member.
  • Candidates must also provide evidence of previous research training and a commitment relevant to the CCRBM research activities and priorities. 
  • Strong emphasis will be given to broad scope lung research training activities with focuses on lung comparative biology and cellular/molecular mechanisms. 
  • Faculty preceptors will direct research training in five primary areas: 1) stem cell biology, regenerative medicine and lung cancer malignancy; 2) airway pathophysiology; 3) lung toxo-pharmacology; 4) lung inflammation and immunity; and 5) translational research.  The training program includes an organized core curriculum consisting of research training in scientific ethics and paper/grant writing strategies, basic lung pathobiology, immunology and new technology in proteomics, genomics and metabolomics, and clinical and translational research through our association with the UC Davis Clinical and Translational Science Center (CTSC).

How to Apply

New applicants must complete application consists of the following:

  • Biographical sketch or CV
  • Career goals (1 page limit)
  • Proposed research plan (1 page limit)
  • Copy of graduate and undergraduate academic records
  • Nomination/support letter from sponsored faculty trainer/mentor


Continuing participant must submit a renewal application that consists of the following:

  • Biographical sketch or CV
  • Progress report (1 page limit)
  • Nomination/support letter from sponsored faculty trainer/mentor


Submit applications to via email as one PDF file to Ms. Chue Xiong (cvxiong@ucdavis.edu) by 11:59 PM (midnight) by the deadline: March 1 for renewal applications; and April 1 for new application.  Applications will be reviewed by the executive committee members of the training program.  An award summary and details will be disclosed in the acceptance letter to the awardee by May 1. 

UCD is an equal opportunity employer

Curricular Activities

  • Summer Course
  • CCRBM Seminar Series

During the seminar series, all trainees and faculty trainers will have the opportunity to present their research-in-progress to the group.  We will also invite speakers from the campus whose research is of interest to the group.  In addition, we will invite distinguished speakers who are experts in the field of our research focus group on a bi-monthly basis (a total of 6 speakers per year).

  • Annual Lung Day
  • Journal Clubs
  • Evening Dinners
  • Learning Groups
  • K30 Workshops
  • Graduate Studies Workshops


Program Director

Nicholas Kenyon, M.D., M.A.S.
Director and Mentor
Department of Internal Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine


Timothy E. Albertson, M.D., M.P.H., Ph.D., Pulmonary and critical care medicine, medicine, pharmacology and toxicology, anesthesia and emergency medicine

Mark Avdalovic, M.D.,  M.A.S., Pulmonary hypertension and asthma and allergic airways disease

Nicole Baumgarth, D.V.M., Ph.D., Regulation of immune responses to pathogens with emphasis on influenza virus infection and HIV; mucosal immunology; respiratory tract immunology; molecular regulation of early B cell activation; and function and development of B-1 cells.

Deborah Bennett, Ph.D., Transport and exposure of chemicals in both indoor and multimedia environments with the context of both environmental risk assessment and epidemiology & assessment of environmental contaminants and patterns

Lars Berglund, M.D., Ph.D., Lipoprotein metabolism

Charles Bevins, M.D., Ph.D., Innate immunity; mucosal host defense; defenses

Xinbin Chen, Ph.D., Biochemistry, molecular, cellular and developmental biology: veterinary oncology

Nipavan Chiamvimonvat, M.D., Cardiovascular biology and medicine: diabetes, hypertension and inflammatory disorders

Carroll E. Cross, M.D., Lung oxidative and nitrosative biology and medicine

Satya Dandekar, Ph.D., Microbiology and Immunology: molecular pathogenesis of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections

Cristina Davis, Ph.D., Airway breath condensates and breath analysis

Angela Haczku, M.D., Ph.D., Pulmonary physiology, airway inflammation and the underlying immune regulatory mechanisms, including inflammatory phenotype in response to environmental exposures to air pollution, cigarette smoke, allergen inhalation and psychosocial stress.

David R. Gandara, M.D., Thoracic oncology and comprehensive oncology

Tzipora Goldkorn, Ph.D., Lung cell biology and signaling systems

Bruce Hammock, Ph.D., Soluble epoxide hydrolase inhibitors as anti-hypertensive & anti-inflammatory agents

Richart W. Harper, M.D., Lung cell biology and oxidative biology

Paul T. Henderson, Ph.D., Mass spectrometry to cancer-related problems

Karen Kelly, M.D., Early detection, preventions and treatment of lung cancer

Nicholas J. Kenyon, M.D., M.A.S., Airway inflammation and fibrosis; lung physiology;  environmental effects on lung function; the role of nitric oxide in airway diseases; asthma; COPD; lung injury

Anne A. Knowlton, M.D., Roles of heat shock proteins in cardiovascular diseases

Kit Lam, M.D., Ph.D., Combinatorial chemistry, chemical biology, drug development, molecular imaging, nanotherapeutics and medical oncology

Jerold A. Last, Ph.D., Lung toxicology and connective tissue biology

Pamela Lein, Ph.D., Neuropharmacology and neurotoxicology and cell and molecular mechanisms of neural plasticity and their role as targets for growth factors, inflammatory mediators & neurotoxicants

K.C. Kent Lloyd, D.V.M., Ph.D., Integrative physiology, murine transgenics and ES cell biology

Su Hao Lo, Ph.D., Signaling transduction mediated through focal adhesions and their roles in tissue and disease development

Lisa Miller, Ph.D., Lung immunology and neonatal immunity

Jan A. Nolta, Ph.D., Stem cell research and  treating disease and tissue injury

Brian M. Morrissey, M.D., Airway disease and cystic fibrosis

Kent E. Pinkerton, Ph.D., Inhalation lung toxicology and injury and repair

Edward S. Schelegle, Ph.D., Lung pathophysiology and airway hypersensitivity

Marc B. Schenker, M.D., M.P.H., Epidemiology  and occupational health, respiratory disease, pesticide illnesses, skin disease, acute and chronic musculoskeletal injuries, adverse pregnancy outcomes, heat stress, and cancer

Michael Schivo, M.D., M.A.S., Asthma and emphysema

Scott I. Simon, Ph.D., inflammation: focus on leukocyte-endothelial interactions

Alice Tarantal, Ph.D., Translational research focusing on stem cells   and gene therapy

Laura S. Van Winkle, Ph.D., Lung Cell Biology, Toxicology and Remodeling

Reen Wu, Ph.D., Lung Cell and Molecular Biology

Amir Zeki, M.D., M.A.S., Identifying drug-induced lung injury; geoepidemiology of COPD and idiopathic pulmonary fibrosis; Simvastatin inhibits airway hyperreactivity